The real reason why Atlas Iron Limited doesn't matter to Qube Holdings Ltd

Qube Holdings Ltd (ASX:QUB) is playing down the loss of Atlas Iron Limited's (ASX:AGO) business on 2014-15 earnings. But I think it will be a bigger issue next year, although shareholders shouldn't fret as the real value of Qube lies elsewhere.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Logistics company Qube Holdings Ltd (ASX: QUB) move to reassure investors that it won't be materially impacted by the shutdown of Atlas Iron Limited (ASX: AGO) seems to have worked.

Shares in Qube jumped 1.3% to $2.835 yesterday when the broader market was struggling to keep its head above water.

Qube, which counts Atlas Iron as a customer, said that its current year earnings won't be significantly affected by the iron ore miner's decision to suspend operations in the Pilbara due to the collapse in the iron ore price.

It appears Qube's risk management strategy to allow no single customer to account for more than 5% of group revenue has worked and the "take-or-pay" contract with Atlas Iron has also helped as the miner is still liable to pay for Qube's services regardless of whether any ore is shipped from its mine.

However, Qube could feel a sharper prick to next year's earnings from the loss of shipping volumes from the Atlas Iron contract given that ore shipped from the miner's Pilbara operations accounted for 64% of the 16 million tonnes Qube handled out of the Utah Point facility.

What is characteristic of most logistics companies is high operating leverage due to their relatively large fixed cost base. While Atlas may only account for a few percentage points of total revenue, the contract will almost certainly make a bigger dent to the bottom line.

Moreover, Qube's full year earnings this year are relatively unaffected because the problems with Atlas Iron happened towards the tail end of the financial year ending June 30 and because Atlas Iron has so far continued to pay Qube. But if administrators are called in, it is unlikely that if Atlas Iron can continue to fulfil its payment obligations to Qube.

Under this scenario, analysts will have little choice but to downgrade their earnings expectations for Qube.

This isn't normally a big issue as the downgrades will probably not be very significant in the grand scheme of things.

There are a host of other companies that will be in greater pain from the shutdown of Atlas Iron and the potential suspension of operations from higher cost other iron ore producers such as Fortescue Metals Group Limited (ASX: FMG), BC Iron Limited (ASX: BCI) and Mt Gibson Iron Limited (ASX: MGX).

Luckily Qube ships a lot more than iron ore. It hauls nickel, manganese and copper as well as agricultural goods like grains and fertiliser.

However, any downgrade of Qube's earnings could cause indigestion for shareholders because it is trading on a fairly big premium. To give you an idea, the stock is trading on a price-earnings (P/E) multiple of well over 20 times on 2013-14 earnings and its P/E is unlikely to fall below 20 for the next year or two.

But investors shouldn't be too alarmed. The real value of Qube (and the reason I bought the stock) is in its yet-to-be constructed Moorebank Intermodal Terminal.

An announcement on this could come at the end of the month and it's the key reason why Macquarie upgraded the stock to "outperform" two weeks ago.

The broker feels that the market has not fully appreciated the value of Moorebank facility, which is strategically located to connect Sydney's port to major road and rail corridors.

Macquarie believes that Qube's P/E falls to a very attractive 12x in 2017-18.

I know that feels like a long time away but as the market has consistently underestimated the company and given management's good track record, I am happy to give the company time to realise the potential of Moorebank.

Motley Fool contributor Brendon Lau owns shares in Qube. Follow me on Twitter - https://twitter.com/brenlau We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policyThis article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »